-transparent.png){kind=logo}
Serial rosette inhibition tests were performed on nine patients with Crohn's disease undergoing immunosuppressive therapy in an attempt to estimate the minimum amount of drug necessary to maintain immunosuppression. The rosette inhibition titre was found to be higher in immunosuppressed patients than in normal subjects. However, there was no consistent correlation of the rosette inhibition titre with the degree of activity of the disease. The test is therefore not sufficiently discriminative to be used as a basis on which to control drug dosage.
Related Publications
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
December 1973,
British medical journal,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
September 1976,
Journal of clinical pathology,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
November 1971,
British medical journal,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
January 1975,
Scandinavian journal of gastroenterology,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
July 1971,
British medical journal,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
February 1985,
Journal of reproductive immunology,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
August 1972,
Transplantation,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
June 1975,
Bollettino dell'Istituto sieroterapico milanese,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
September 1972,
British medical journal,
J R Clarke, and
E R Richens, and
M J Williams, and
K R Gough, and
R J Ancill
September 1982,
Clinical reproduction and fertility,
